L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension

Sherief Abd-Elsalam60 enrolled

Overview

This study compares L-arginine Versus Sildenafil as treatment for pulmonary hypertension in Children with Beta Thalassemia

This study focuses on different lines of treatment for pulmonary hypertension in children with thalassemia as this study discusses the Effect of L-arginine Versus Sildenafil in Children with Beta Thalassemia Associated with Pulmonary Hypertension

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Thalassemia

Interventions

L-arginineDRUG

l-arginine for thalassemia with pulmonary hypertension

SildenafilDRUG

Sildenafil for thalassemia with pulmonary hypertension

Eligibility

Sex: ALLMin age: 6 YearsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Children with thalassemia and pulmonary hypertension. Exclusion Criteria: * Rheumatic heart diseases. * Other comorbid disease

Locations (1)

Sherief Abd-Elsalam

Tanta, Egypt

RECRUITING

Outcomes

Primary Outcomes

Number of patients with improvement of pulmonary hypertension

patients with improvement of pulmonary hypertension

Time frame: 6 months

Central Contacts

Sherief Abd-Elsalam, MD

CONTACT

00201095159522 sheriefabdelsalam@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.